Cannabidiol (CBD) Products

Download PDF

What is cannabidiol (CBD)?1,2

Cannabis (or marijuana) has been a controlled substance in the United States since 1970. CBD is one of the main chemicals in cannabis. CBD does not cause the same effect of “getting high” as marijuana because it does not contain the psychoactive ingredient, tetrahydrocannabinol (THC). CBD can be bought in the form of an oil, capsules, shampoo, skin cream, and other formulations.

  1. FDA Regulation of Cannabis and Cannabis-Derived Products: Questions and Answers. [Internet]. March 10, 2022 [cited March 10, 2022]. March 10, 2022. Available from: https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd.
  2. CANNABIDIOL (CBD) Critical Review Report. 2018. 2018.
  3. What You Need to Know (And What We’re Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD.
  4. Iffland K, Grotenhermen F. An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies. Cannabis Cannabinoid Res. 2017 Jan;2(1):139-154. SAGE Publications; 2017 Jan. DOI: 10.1089/can.2016.0034.
  5. Blake R, Valmassy R. Podiatric sports medicine: runner's knee examination form. J Am Podiatry Assoc. 1981 Jul;71(7):397-403. MDPI AG; 1981 Jul. DOI: 10.7547/87507315-71-7-397.
  6. Food and Drug Administration, Publi. FDA Boxed Warning for Immediate-Release Opioids. J Pain & Palliat Care Pharmacother. 2016 Apr 2;30(2):141-145. Informa UK Limited; 2016 Apr 2. DOI: 10.3109/15360288.2016.1173762.
  7. Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping products. 2021 Aug 3 [cited 2022 May 12]. 2021 Aug 3.
  8. Thiele EA, Marsh ED, French JA, Mazurkiewicz-Beldzinska M, Benbadis SR, Joshi C, et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2018 Mar;391(10125):1085-1096. Elsevier BV; 2018 Mar. DOI: 10.1016/s0140-6736(18)30136-3.
  9. Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, et al. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. N Engl J Med. 2017 May 25;376(21):2011-2020. Massachusetts Medical Society; 2017 May 25. DOI: 10.1056/nejmoa1611618.
  10. FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy. [Internet]. 2018 Jun 5 [cited 2019 Sep 20]. 2018 Jun 5. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-comprised-active-ingredient-derived-marijuana-treat-rare-severe-forms.